Tisagenlecleucel CAR-T receives additional FDA Approval for DLBCL

Tisagenlecleucel CAR-T receives additional FDA Approval for DLBCL

See all CAR-T therapies and indications

 

Ribociclib FDA label updated to include pre- and perimenopausal women
  • Save
1 reply

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply